HomeCompareAZYO vs PLD

AZYO vs PLD: Dividend Comparison 2026

AZYO yields 134.23% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AZYO wins by $7.92M in total portfolio value
10 years
AZYO
AZYO
● Live price
134.23%
Share price
$1.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.42M
Annual income
$5,849,084.49
Full AZYO calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — AZYO vs PLD

📍 AZYO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAZYOPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AZYO + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AZYO pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AZYO
Annual income on $10K today (after 15% tax)
$11,409.40/yr
After 10yr DRIP, annual income (after tax)
$4,971,721.82/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, AZYO beats the other by $503,751.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AZYO + PLD for your $10,000?

AZYO: 50%PLD: 50%
100% PLD50/50100% AZYO
Portfolio after 10yr
$10.46M
Annual income
$5,552,760.34/yr
Blended yield
53.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

AZYO
Analyst Ratings
4
Buy
Consensus: Buy
Price Target
$10.25
+587.9% upside vs current
Range: $10.00 — $10.50
Altman Z
-3.7
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AZYO buys
0
PLD buys
0
No recent congressional trades found for AZYO or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAZYOPLD
Forward yield134.23%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$14.42M$6.50M
Annual income after 10y$5,849,084.49$5,256,436.18
Total dividends collected$13.23M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$10.25$136.00

Year-by-year: AZYO vs PLD ($10,000, DRIP)

YearAZYO PortfolioAZYO Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$24,123$13,422.82$11,255$555.24+$12.9KAZYO
2$56,073$30,261.33$13,062$1,018.59+$43.0KAZYO
3$125,738$65,739.74$15,903$1,926.67+$109.8KAZYO
4$272,310$137,770.90$20,839$3,823.32+$251.5KAZYO
5$570,223$278,851.11$30,464$8,166.08+$539.8KAZYO
6$1,155,858$545,719.55$52,054$19,457.30+$1.10MAZYO
7$2,270,590$1,033,821.54$109,886$54,188.93+$2.16MAZYO
8$4,327,530$1,897,998.85$304,030$186,451.18+$4.02MAZYO
9$8,011,211$3,380,754.03$1,166,125$840,813.32+$6.85MAZYO
10$14,421,080$5,849,084.49$6,504,190$5,256,436.18+$7.92MAZYO

AZYO vs PLD: Complete Analysis 2026

AZYOStock

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Full AZYO Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this AZYO vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AZYO vs SCHDAZYO vs JEPIAZYO vs OAZYO vs KOAZYO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.